{"Q": 1, "answer": "no", "rationale": "The segment uses 'infectious', which is a factual description, not an intensified risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_15020", "batch_size": 260, "batch_pos": 91, "statement_text": "WastewaterSCAN, an infectious disease-tracking sewage surveillance network led by Stanford University and Emory University in partnership with Verily Life Sciences, has begun scaling up H5-specific testing of samples from all of its 190 sites at treatment plants across 36 states.", "article_id": 582}
{"Q": 2, "answer": "no", "rationale": "The segment describes actions using neutral language.", "method": "llm_batch", "batch_id": "batch_2_2828", "batch_size": 260, "batch_pos": 83, "statement_text": "WastewaterSCAN, an infectious disease-tracking sewage surveillance network led by Stanford University and Emory University in partnership with Verily Life Sciences, has begun scaling up H5-specific testing of samples from all of its 190 sites at treatment plants across 36 states.", "article_id": 582}
{"Q": 3, "answer": "no", "rationale": "The segment reports scaling up testing but does not contain a moderate verb paired with significant scale or impact.", "method": "llm_batch", "batch_id": "batch_3_4844", "batch_size": 260, "batch_pos": 23, "statement_text": "WastewaterSCAN, an infectious disease-tracking sewage surveillance network led by Stanford University and Emory University in partnership with Verily Life Sciences, has begun scaling up H5-specific testing of samples from all of its 190 sites at treatment plants across 36 states.", "article_id": 582}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_14732", "batch_size": 260, "batch_pos": 6, "statement_text": "WastewaterSCAN, an infectious disease-tracking sewage surveillance network led by Stanford University and Emory University in partnership with Verily Life Sciences, has begun scaling up H5-specific testing of samples from all of its 190 sites at treatment plants across 36 states.", "article_id": 582}
{"Q": 5, "answer": "no", "rationale": "Describes a surveillance effort but lacks explicit calming language or required keywords.", "method": "llm_batch", "batch_id": "batch_5_9336", "batch_size": 260, "batch_pos": 3, "statement_text": "WastewaterSCAN, an infectious disease-tracking sewage surveillance network led by Stanford University and Emory University in partnership with Verily Life Sciences, has begun scaling up H5-specific testing of samples from all of its 190 sites at treatment plants across 36 states.", "article_id": 582}
{"Q": 6, "answer": "no", "rationale": "The segment describes scaling up testing (Q5) and reports scale ('190 sites', '36 states') but not the Q6 pattern.", "method": "llm_batch", "batch_id": "batch_6_17264", "batch_size": 260, "batch_pos": 247, "statement_text": "WastewaterSCAN, an infectious disease-tracking sewage surveillance network led by Stanford University and Emory University in partnership with Verily Life Sciences, has begun scaling up H5-specific testing of samples from all of its 190 sites at treatment plants across 36 states.", "article_id": 582}
